Concepedia

Quantitative determination of the HIV protease inhibitor atazanavir (BMS-232632) in human plasma by liquid chromatography–tandem mass spectrometry following automated solid-phase extraction

Alan Schuster, S Burzawa, Mohammed Jemal, E Loizillon, Philippe Couerbe, Daisy B. Whigan

Journal of Chromatography B · 2003 · 43 citations · 5 references

DOI

Concepts

References

5

Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studies

Vinod P. Shah, K.K. Midha, S Dighe et al. · European Journal of Drug Metabolism and Pharmacokinetics · 1991 · 617 citations

, , +14

Selective biotransformation of the human immunodeficiency virus protease inhibitor saquinavir by human small-intestinal cytochrome P4503A4: potential contribution to high first-pass metabolism.

Michael E. Fitzsimmons, Jerry M. Collins · PubMed · 1997 · 224 citations

, , +17

In Vitro Resistance Profile of the Human Immunodeficiency Virus Type 1 Protease Inhibitor BMS-232632

Yi-Fei Gong, Brett S. Robinson, Ronald E. Rose et al. · Antimicrobial Agents and Chemotherapy · 2000 · 132 citations

, , +17

Hollow‐Fiber Unit Evaluation of a New Human Immunodeficiency Virus Type 1 Protease Inhibitor, BMS‐232632, for Determination of the Linked Pharmacodynamic Variable

George L. Drusano, John A. Bilello, Sandra L. Preston et al. · The Journal of Infectious Diseases · 2001 · 50 citations · Full text

, , +17

Quantification of the anti‐HIV drug saquinavir by high‐speed on‐line high‐performance liquid chromatography/tandem mass spectrometry

Norbert Knebel, Stephen R Sharp, Michael J. Madigan · Journal of Mass Spectrometry · 1995 · 38 citations

, , +17